Tortoise Investment Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-397
| Closed | -$50.9K | – | 1562 |
|
|
2025
Q2 | $50.9K | Buy |
397
+1
| +0.3% | +$104 | ﹤0.01% | 382 |
|
|
2025
Q1 | $35K | Hold |
396
| – | – | ﹤0.01% | 420 |
|
|
2024
Q4 | $34.5K | Hold |
396
| – | – | ﹤0.01% | 481 |
|
|
2024
Q3 | $36.6K | Sell |
396
-220
| -36% | -$21.9K | ﹤0.01% | 466 |
|
|
2024
Q2 | $66.4K | Hold |
616
| – | – | 0.01% | 351 |
|
|
2024
Q1 | $58.4K | Sell |
616
-250
| -29% | -$21.4K | 0.01% | 364 |
|
|
2023
Q4 | $79.9K | Hold |
866
| – | – | 0.01% | 307 |
|
|
2023
Q3 | $43.5K | Hold |
866
| – | – | 0.01% | 358 |
|
|
2023
Q2 | $54.7K | Hold |
866
| – | – | 0.01% | 342 |
|
|
2023
Q1 | $39K | Hold |
866
| – | – | 0.01% | 360 |
|
|
2022
Q4 | $37.9K | Hold |
866
| – | – | 0.01% | 360 |
|
|
2022
Q3 | $57K | Hold |
866
| – | – | 0.01% | 298 |
|
|
2022
Q2 | $44K | Hold |
866
| – | – | 0.01% | 318 |
|
|
2022
Q1 | $55K | Hold |
866
| – | – | 0.01% | 290 |
|
|
2021
Q4 | $93K | Hold |
866
| – | – | 0.02% | 224 |
|
|
2021
Q3 | $89K | Hold |
866
| – | – | 0.02% | 206 |
|
|
2021
Q2 | $76K | Sell |
866
-100
| -10% | -$9.16K | 0.02% | 221 |
|
|
2021
Q1 | $94K | Hold |
966
| – | – | 0.02% | 203 |
|
|
2020
Q4 | $108K | Hold |
966
| – | – | 0.02% | 187 |
|
|
2020
Q3 | $90K | Hold |
966
| – | – | 0.02% | 185 |
|
|
2020
Q2 | $75K | Hold |
966
| – | – | 0.02% | 196 |
|
|
2020
Q1 | $56K | Hold |
966
| – | – | 0.02% | 212 |
|
|
2019
Q4 | $77K | Hold |
966
| – | – | 0.02% | 209 |
|
|
2019
Q3 | $71K | Hold |
966
| – | – | 0.02% | 204 |
|
|
2019
Q2 | $91K | Hold |
966
| – | – | 0.02% | 196 |
|
|
2019
Q1 | $77K | Hold |
966
| – | – | 0.02% | 206 |
|
|
2018
Q4 | $52K | Hold |
966
| – | – | 0.01% | 229 |
|
|
2018
Q3 | $75K | Hold |
966
| – | – | 0.02% | 209 |
|
|
2018
Q2 | $61K | Sell |
966
-500
| -34% | -$39.8K | 0.02% | 226 |
|
|
2018
Q1 | $134K | Hold |
1,466
| – | – | 0.04% | 161 |
|
|
2017
Q4 | $111K | Hold |
1,466
| – | – | 0.03% | 177 |
|
|
2017
Q3 | $102K | Hold |
1,466
| – | – | 0.03% | 180 |
|
|
2017
Q2 | $74K | Hold |
1,466
| – | – | 0.02% | 184 |
|
|
2017
Q1 | $59K | Hold |
1,466
| – | – | 0.02% | 185 |
|
|
2016
Q4 | $41K | Hold |
1,466
| – | – | 0.01% | 216 |
|
|
2016
Q3 | $44K | Hold |
1,466
| – | – | 0.01% | 205 |
|
|
2016
Q2 | $30K | Hold |
1,466
| – | – | 0.01% | 237 |
|
|
2016
Q1 | $26K | Sell |
1,466
-730
| -33% | -$12.7K | 0.01% | 236 |
|
|
2015
Q4 | $58K | Buy |
+2,196
| New | +$49.4K | 0.02% | 195 |
|
Other funds holding BPMC
IA
HNB
Tortoise Investment Management's BPMC Position: Q3 2025 in Review
Tortoise Investment Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 397 shares — an estimated $50.9K sold.
Tortoise Investment Management first reported a position in BPMC in Q4 2015 and held it in 39 quarters. The position peaked at $134K in Q1 2018. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Tortoise Investment Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Tortoise Investment Management sold 397 Blueprint Medicines shares in Q3 2025, an estimated $50.9K.
- Tortoise Investment Management first reported a position in Blueprint Medicines in Q4 2015 and held it in 39 quarters.
- Tortoise Investment Management's Blueprint Medicines position peaked at $134K in Q1 2018.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Tortoise Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.